Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis and haemostasis, and vascular biology.
News Appointments made for new Director and Deputy Director of Clinical Research Professor Jon Townend and Dr Rick Steeds have been appointed Director and Deputy Director of Clinical Research respectively for the Institute of Cardiovascular Sciences (ICVS), further enhancing the integration of clinical research in the Institute.
News Kidney donation does not increase the risk of cardiovascular disease for donors, research confirms
News Artificial Intelligence approach helps to identify patients with heart failure that respond to beta-blocker treatment
03 May 2022 Birmingham cardiovascular scientists appointed editor and deputy editor of international journals Professor Neil Morgan and Dr Davor Pavlovic are joining Frontiers in Cardiovascular Medicine and Journal of Molecular and Cellular Cardiology Plus respectively.
14 January 2022 New research to investigate methods of measuring heart function to improve care Dr Karina Bunting has been awarded a Career Development Fellowship to determine whether a new method of measuring heart function in patients with atrial fibrillation improves accuracy.
20 December 2021 Dr Nicolson awarded 2021 Science Communication Prize Dr Pip Nicholson, Clinical Lecturer in Haematology, is awarded this year's Furness Prize for Science Communication for showing excellence in science communication activities throughout the year.
10 December 2021 New clinical trial aims to improve heart protection during surgery in children A new clinical trial being led by the University of Birmingham and funded by the British Heart Foundation could help improve the recovery of children who undergo life-saving heart surgery.
11 October 2021 Milestone moment for the region's life science sector as construction on No. 1 Birmingham Health Innovation Campus gets underway Construction of No.1 Birmingham Health Innovation Campus (BHIC) in Selly Oak is underway, marking a major milestone for the region's rapidly growing life sciences sector.
21 September 2021 Kidney donation does not increase the risk of cardiovascular disease for donors, research confirms The study has confirmed that donating a kidney does not have an adverse effect on a donor's cardiovascular system or blood pressure for at least five years.
31 August 2021 Artificial Intelligence approach helps to identify patients with heart failure that respond to beta-blocker treatment Researchers at the University of Birmingham have developed a new way to identify which patients with heart failure will benefit from treatment with beta-blockers.
25 August 2021 Birmingham scientists discover new piece of clotting puzzle In research that provides a new perspective on how blood clotting works in infectious and inflammatory diseases, Birmingham scientists have described a potential new target and strategy for anti-thrombotic therapy.
04 August 2021 New research to find out what damage diabetes does to the smallest blood vessels of the heart in order to develop new therapies Dr Neena Kalia, Reader at the Institute of Cardiovascular Sciences, has been awarded a three-year BHF research grant to find out what damage diabetes does to the smallest blood vessels of the heart.
04 August 2021 New Birmingham-Roche collaboration targets new treatments for inflammatory bowel disease A new £850k collaboration between Birmingham Health Partners and global biotechnology leaders Roche is set to improve both diagnosis and care of patients with inflammatory bowel disease.
13 July 2021 Partnership will create the next generation of researchers to transform global healthcare The Universities of Birmingham, Leicester and Nottingham have launched a partnership training the next generation of leading researchers the skills required to transform our understanding and treatment of disease.
29 June 2021 Launch of the national Congenital Heart Disease Priority Setting Partnership Today, 29 June 2021, sees the launch of the UK's first national study to identify research priorities for children and adults diagnosed with congenital heart disease (CHD).